This move is archived. Current quotes and coverage live on the stock page.
Follow APLI
A significant drop in stock price raises questions about Appili Therapeutics Inc's future.
Appili Therapeutics Inc experienced a sharp decline in its stock price, falling by 33.33% in yesterday's trading session. This drop brings the company's share price down to CA$0.01, a concerning figure for investors who have been keeping a close watch on the biotech sector.
Investor takeaway: Investors should closely monitor Appili's strategic direction and market response, particularly in the biodefence sector where it aims to reposition itself.
Advertisement
Appili Therapeutics Inc
APLI.TO
APLI.TO
Appili Therapeutics Inc
WealthAwesomeMarket cap
$661,830
52W high
$0.03
52W low
$0.01
1W change
-50.00%
Beta
-0.19
Analyst Price Targets
Based on analyst covering APLI · as of Sep 17, 2026
Wall Street analysts forecast APLI stock price to rise 2900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+2900.0% Upside
Current Price
C$0.01
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
473.3%
Annualized
90-Day Vol
313.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.00 | C$0.00 – C$0.02 |
| 60 trading days | C$0.00 | C$0.00 – C$0.04 |
| 90 trading days | C$0.00 | C$0.00 – C$0.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Stock Price Drops to CA$0.01
The 33.33% drop in stock price reflects significant investor concern over Appili's financial health and operational strategy.
Bull case
If Appili can effectively implement its new business strategy focused on biodefence, it might attract new investment and regain investor confidence.
Bear case
Ongoing financial losses and uncertainty about its operational results could lead to further declines in stock value, making it a risky investment.
Advertisement
Market Reaction
The significant drop in Appili's stock price has raised eyebrows among investors, especially given the company's recent strategic shift towards the biodefence sector. With a market cap now at CA$1,324,661, the decline signals a lack of confidence in its new direction.
Understanding the Decline
Investors might be worried about Appili's ability to execute its new business strategy effectively. The absence of recent positive news or operational updates has left many questioning the company's future prospects. As seen in the past, biotech stocks can be highly volatile, and Appili's recent performance exemplifies this risk.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
